Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Angel Oak Mortgage REIT | AOMR | 18. oct 2024 | 9.79 | -0.51 |
Anghami | ANGH | 18. oct 2024 | 0.80 | +1.27 |
Angi A | ANGI | 18. oct 2024 | 2.56 | +1.99 |
AngioDynamics | ANGO | 18. oct 2024 | 6.39 | +0.79 |
Anglogold Ashanti | AU | 18. oct 2024 | 30.33 | +2.74 |
Anheuser-Busch InBev ADR | BUD | 18. oct 2024 | 66.04 | +0.87 |
ANI Pharmaceuticals | ANIP | 18. oct 2024 | 60.31 | +0.32 |
Anika Therapeutics | ANIK | 18. oct 2024 | 25.06 | -0.36 |
Anixa Biosciences | ANIX | 18. oct 2024 | 3.01 | +0.67 |
Annaly Capital Management | NLY | 18. oct 2024 | 20.28 | +0.65 |
Annaly Capital Management F Pref | NLY-F | 18. oct 2024 | 25.76 | +0.16 |
Annaly Capital Management G Pref | NLY-G | 18. oct 2024 | 25.38 | +0.16 |
Annaly Capital Management I Pref | NLY-I | 18. oct 2024 | 25.71 | +0.23 |
Annexon | ANNX | 18. oct 2024 | 7.48 | -1.97 |
Annovis Bio | ANVS | 18. oct 2024 | 9.21 | +6.35 |
ANSYS | ANSS | 18. oct 2024 | 327.40 | +0.25 |
Antelope Enterprise | AEHL | 18. oct 2024 | 0.54 | -6.65 |
Anterix | ATEX | 18. oct 2024 | 33.39 | -0.03 |
Antero Midstream | AM | 18. oct 2024 | 15.15 | +0.07 |
Antero Resources | AR | 18. oct 2024 | 26.84 | -1.69 |
Anywhere Real Estate | HOUS | 18. oct 2024 | 4.66 | +3.56 |
Aon | AON | 18. oct 2024 | 357.93 | -0.23 |
APA | APA | 18. oct 2024 | 25.16 | +0.96 |
Apartment Investment and Management | AIV | 18. oct 2024 | 8.83 | +0.57 |
Apellis Pharmaceuticals | APLS | 18. oct 2024 | 28.00 | +0.29 |
APi Group | APG | 18. oct 2024 | 33.99 | -0.06 |
Apogee Enterprises | APOG | 18. oct 2024 | 78.85 | -0.17 |
Apogee Therapeutics | APGE | 18. oct 2024 | 53.53 | -4.80 |
Apollo Commercial Real Estate Finance | ARI | 18. oct 2024 | 8.90 | 0.00 |
Apollo Global Management | APO | 18. oct 2024 | 145.01 | -0.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.